[3-(4-amino-1,2,5-oxadiazol-3-yl)-5-[[(5-nitro-2-furyl)methylideneamino]carbamoyl]triazol-4-yl]methyl-dipropyl-azanium
Molecular Formula:
C17H23N10O5+
InChI: InChI=1/C17H22N10O5/c1-3-7-25(8-4-2)10-12-14(20-24-26(12)16-15(18)22-32-23-16)17(28)21-19-9-11-5-6-13(31-11)27(29)30/h5-6,9H,3-4,7-8,10H2,1-2H3,(H2,18,22)(H,21,28)/p+1/fC17H23N10O5/h21,25H,18H2/q+1
InChIKey: InChIKey=ZVVYQRFDPYANKY-AHCVUMIJCS
SMILES: CCC[NH+](CCC)CC1=C(N=NN1C2=NON=C2N)C(=O)NN=CC3=CC=C(O3)[N+](=O)[O-]
Names:
[3-(4-amino-1,2,5-oxadiazol-3-yl)-5-[[(5-nitro-2-furyl)methylideneamino]carbamoyl]triazol-4-yl]methyl-dipropyl-azanium
Registries:
PubChem CID 4103940
PubChem ID 6027272
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|